ECM
ALT icon

Element Capital Management’s Altimmune ALT Stock Holding History

Element Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,576
Closed -$151K – 65
2017
Q2 		$151K Buy
+1,576
New +$262K 0.03% 113

Other funds holding ALT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Element Capital Management's ALT Position: Q3 2017 in Review

Element Capital Management sold out of Altimmune (ALT) in Q3 2017, closing a stake of 1,576 shares — an estimated $151K sold.

Element Capital Management first reported a position in ALT in Q2 2017 and held it in 1 quarter. The position peaked at $151K in Q2 2017. 29 funds tracked by Wall St. Rank hold ALT as of Q3 2017.

  • Element Capital Management reported no remaining Altimmune position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 1,576 Altimmune shares in Q3 2017, an estimated $151K.
  • Element Capital Management first reported a position in Altimmune in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's Altimmune position peaked at $151K in Q2 2017.
  • 29 funds tracked by Wall St. Rank held Altimmune as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.